These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 19291792)

  • 1. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
    Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
    Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathological characteristics of glioma stem cell niches.
    He H; Li MW; Niu CS
    J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlative study of distribution of brain tumor stem cell with micro-vascular system].
    Li MW; Niu CS
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Girdin maintains the stemness of glioblastoma stem cells.
    Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
    Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasion of primary glioma- and cell line-derived spheroids implanted into corticostriatal slice cultures.
    Aaberg-Jessen C; Nørregaard A; Christensen K; Pedersen CB; Andersen C; Kristensen BW
    Int J Clin Exp Pathol; 2013; 6(4):546-60. PubMed ID: 23573302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cancer stem cells from the C6 glioma cell line.
    Zhou XD; Wang XY; Qu FJ; Zhong YH; Lu XD; Zhao P; Wang DH; Huang QB; Zhang L; Li XG
    J Int Med Res; 2009; 37(2):503-10. PubMed ID: 19383245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.
    Wang J; Wang X; Jiang S; Lin P; Zhang J; Wu Y; Xiong Z; Ren JJ; Yang H
    Cell Mol Neurobiol; 2008 Nov; 28(7):991-1003. PubMed ID: 18350379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell markers in gliomas.
    Dell'Albani P
    Neurochem Res; 2008 Dec; 33(12):2407-15. PubMed ID: 18493853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the clinical value of cancer stem cell markers in gliomas?
    Dahlrot RH; Hermansen SK; Hansen S; Kristensen BW
    Int J Clin Exp Pathol; 2013; 6(3):334-48. PubMed ID: 23412423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface Nestin is a biomarker for glioma stem cells.
    Jin X; Jin X; Jung JE; Beck S; Kim H
    Biochem Biophys Res Commun; 2013 Apr; 433(4):496-501. PubMed ID: 23524267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and partial characterization of a new human glioblastoma cell line.
    Brehar FM; Bleotu C; Stefan LM; Buzgariu W; Chivu M; Utoiu E; Matei L; Ciurea AV; Tascu A
    Chirurgia (Bucur); 2009; 104(4):453-61. PubMed ID: 19886054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype.
    Salmaggi A; Boiardi A; Gelati M; Russo A; Calatozzolo C; Ciusani E; Sciacca FL; Ottolina A; Parati EA; La Porta C; Alessandri G; Marras C; Croci D; De Rossi M
    Glia; 2006 Dec; 54(8):850-60. PubMed ID: 16981197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3.
    Wan Y; Fei XF; Wang ZM; Jiang DY; Chen HC; Yang J; Shi L; Huang Q
    Chin J Cancer; 2012 Apr; 31(4):207-14. PubMed ID: 22360855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
    Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
    Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limits of CD133 as a marker of glioma self-renewing cells.
    Clément V; Dutoit V; Marino D; Dietrich PY; Radovanovic I
    Int J Cancer; 2009 Jul; 125(1):244-8. PubMed ID: 19350631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells.
    Choi SA; Wang KC; Phi JH; Lee JY; Park CK; Park SH; Kim SK
    Cancer Lett; 2012 Nov; 324(2):221-30. PubMed ID: 22652175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
    Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
    Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.
    Ogden AT; Waziri AE; Lochhead RA; Fusco D; Lopez K; Ellis JA; Kang J; Assanah M; McKhann GM; Sisti MB; McCormick PC; Canoll P; Bruce JN
    Neurosurgery; 2008 Feb; 62(2):505-14; discussion 514-5. PubMed ID: 18382330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
    Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
    Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.